Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| HAE | HAEMONETICS CORP | 2026-05-22 14:59:41 | 65.52 | 3.6 | 5.81 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HAE | 0000313143 | HAEMONETICS CORP | US4050241003 | 549300ZEL6TXZS6F5F95 | 042882273 | NYSE | 3841 | Surgical & Medical Instruments & Apparatus | 0328 | MA | 125 SUMMER STREET | BOSTON | MA | 02110 | UNITED STATES | US | 7818487100 | 125 SUMMER STREET, BOSTON, MA, 02110 | 125 SUMMER STREET, BOSTON, MA, 02110 | — | Medical Devices | 1971 | — | 3,300 | https://haemonetics.com | 2,226,588,933 | 45,252,667 | 45,445,983 | Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. | 2026-05-21 16:42:21 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2026 | 2,226,588,933 | -1,756,891,646 | -44.1044 | 45,445,983 | -2,591,013 | -5.3938 |
| 2025 | 3,983,480,579 | -527,564,247 | -11.6949 | 48,036,996 | -2,804,446 | -5.5161 |
| 2024 | 4,511,044,826 | 785,771,794 | 21.093 | 50,841,442 | 300,672 | 0.5949 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Michelle L. Basil | Executive Vice President, General Counsel | 2025 | 537,870 | 0 | 1,471,617 | 356,242 | 28,715 | 2,794,443 |
| Roy Galvin | Chief Commercial Officer, Executive Vice President | 2025 | 490,154 | 0 | 1,011,733 | 378,263 | 41,204 | 2,196,340 |
| Christopher A. Simon | Chief Executive Officer, President | 2025 | 1,100,000 | 0 | 7,026,668 | 1,131,625 | 64,221 | 10,722,488 |
| James C. D'Arecca | Chief Financial Officer, Executive Vice President | 2025 | 575,582 | 0 | 1,563,677 | 381,872 | 29,580 | 2,975,669 |
| Stewart W. Strong | President | 2025 | 476,702 | 0 | 1,011,733 | 132,120 | 39,162 | 1,934,703 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenue | 1,334,027,000 | 1,360,824,000 | 1,309,055,000 |
| Cost Of Revenue | 546,441,000 | 611,866,000 | 617,507,000 |
| Gross Profit | 787,586,000 | 748,958,000 | 691,548,000 |
| Research And Development Expenses | 59,766,000 | 62,722,000 | 54,435,000 |
| General And Administrative Expenses | 442,421,000 | 436,789,000 | 431,780,000 |
| Operating Expenses | 630,852,000 | 527,141,000 | 526,665,000 |
| Operating Income | 156,734,000 | 221,817,000 | 164,883,000 |
| Net Income | 97,308,000 | 167,679,000 | 117,558,000 |
| Earnings Per Share Basic | 2.06 | 3.33 | 2.32 |
| Earnings Per Share Diluted | 2.05 | 3.31 | 2.29 |
| Weighted Average Shares Outstanding Basic | 47,179,000 | 50,330,000 | 50,706,000 |
| Weighted Average Shares Outstanding Diluted | 47,354,000 | 50,730,000 | 51,397,000 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Cash And Cash Equivalents | 245,440,000 | 306,763,000 | 178,800,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 216,855,000 | 202,657,000 | 206,562,000 |
| Inventories | 306,370,000 | 365,141,000 | 317,202,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 66,214,000 | 60,414,000 | 66,339,000 |
| Total Assets Current | 834,879,000 | 934,975,000 | 768,903,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 305,761,000 | 284,052,000 | 311,362,000 |
| Other Assets Non Current | 141,741,000 | 164,106,000 | 136,388,000 |
| Total Assets Non Current | 305,761,000 | 284,052,000 | 311,362,000 |
| Total Assets | 2,395,925,000 | 2,450,948,000 | 2,195,591,000 |
| Accounts Payable | 51,056,000 | 66,999,000 | 73,358,000 |
| Deferred Revenue | 42,310,000 | 43,348,000 | 31,242,000 |
| Short Term Debt | 5,015,000 | 303,558,000 | 10,229,000 |
| Other Liabilities Current | 158,337,000 | 148,133,000 | 136,088,000 |
| Total Liabilities Current | 282,599,000 | 578,113,000 | 300,383,000 |
| Long Term Debt | 1,239,807,000 | 1,246,120,000 | 797,564,000 |
| Other Liabilities Non Current | 59,393,000 | 68,194,000 | 75,041,000 |
| Total Liabilities Non Current | 1,317,006,000 | 1,051,999,000 | 935,249,000 |
| Total Liabilities | 1,599,605,000 | 1,630,112,000 | 1,235,632,000 |
| Common Stock | 453,000 | 482,000 | 508,000 |
| Retained Earnings | 279,344,000 | 352,174,000 | 360,456,000 |
| Accumulated Other Comprehensive Income | -37,614,000 | -55,084,000 | -35,632,000 |
| Total Shareholders Equity | 796,320,000 | 820,836,000 | 959,959,000 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Depreciation And Amortization | 111,717,000 | 115,586,000 | 97,215,000 |
| Share Based Compensation Expense | 33,827,000 | 29,636,000 | 28,332,000 |
| Other Non Cash Income Expense | 714,000 | 15,698,000 | — |
| Change In Accounts Receivable | 14,881,000 | -6,956,000 | 24,193,000 |
| Change In Inventories | -47,361,000 | 64,704,000 | 60,061,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -16,571,000 | -19,208,000 | 44,582,000 |
| Change In Other Liabilities | 35,028,000 | 25,232,000 | 34,046,000 |
| Cash From Operating Activities | 293,221,000 | 181,725,000 | 181,751,000 |
| Purchases Of Marketable Securities | 36,071,000 | 17,143,000 | 15,551,000 |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 32,780,000 | 39,278,000 | 66,296,000 |
| Acquisition Of Business | 60,180,000 | 150,906,000 | 243,852,000 |
| Other Investing Activities | 36,071,000 | 17,143,000 | 15,551,000 |
| Cash From Investing Activities | -179,547,000 | -161,895,000 | -322,389,000 |
| Tax Withholding For Share Based Compensation | 5,001,000 | 10,243,000 | 5,885,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 6,099,000 | 1,857,000 | 1,610,000 |
| Repurchase Of Common Stock | 175,000,000 | 226,848,000 | 0 |
| Issuance Of Long Term Debt | 300,000,000 | 0 | 110,000,000 |
| Repayment Of Long Term Debt | — | 4,688,000 | 12,250,000 |
| Other Financing Activities | -102,000 | -249,000 | -73,000 |
| Cash From Financing Activities | -178,460,000 | 108,818,000 | 38,157,000 |
| Change In Cash | -61,323,000 | 127,963,000 | -105,666,000 |
| Cash At End Of Period | 245,440,000 | 306,763,000 | 178,800,000 |
| Income Taxes Paid | 60,665,000 | 49,293,000 | 52,706,000 |
| Interest Paid | 17,465,000 | 16,534,000 | 20,901,000 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Earnings Per Share | 2.06 | 3.33 | 2.32 |
| Price To Earnings Ratio | 26.233 | 18.976 | 36.7888 |
| Earnings Growth Rate | -38.1381 | 43.5345 | 2.2026 |
| Price Earnings To Growth Ratio | -0.6878 | 0.4359 | 16.7021 |
| Book Value Per Share | 16.8787 | 16.3091 | 18.9319 |
| Price To Book Ratio | 3.2017 | 3.8745 | 4.5083 |
| Ebitda | 288,990,000 | 368,458,000 | 286,979,000 |
| Enterprise Value | 3,548,935,160 | 4,423,267,700 | 4,956,750,100 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 1.5632 | 1.8879 | 0.8415 |
| Capital Expenditures | 133,426,000 | 88,276,000 | 97,692,000 |
| Free Cash Flow | 159,795,000 | 93,449,000 | 84,059,000 |
| Return On Equity | 0.1222 | 0.2043 | 0.1225 |
| One Year Beta | 0.6368 | 0.483 | 0.7849 |
| Three Year Beta | 0.6264 | 0.7432 | 0.8512 |
| Five Year Beta | 0.7491 | 0.8114 | 0.8351 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Miller Laurie A. | SVP, Human Resources | 2026-05-15 | 948 | D | 27,977 |
| Miller Laurie A. | SVP, Human Resources | 2026-05-15 | 13,323 | A | 41,300 |
| Galvin Roy | EVP, Chief Commercial Officer | 2026-05-15 | 879 | D | 12,347 |
| Galvin Roy | EVP, Chief Commercial Officer | 2026-05-15 | 27,535 | A | 39,882 |
| Maunsell Farris Maryanne | VP, Chief Accounting Officer | 2026-05-15 | 197 | D | 4,281 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Lois Frankel | 2021-05-25 | FL21 | Sale | 2021-05-07 | — | $1,001 - $15,000 |
| Lois Frankel | 2021-05-25 | FL21 | Sale (Partial) | 2021-05-06 | — | $1,001 - $15,000 |
| Josh Gottheimer | 2021-02-09 | NJ05 | Sale | 2021-01-25 | Joint | $1,001 - $15,000 |
| Lois Frankel | 2018-06-22 | FL21 | Sale (Partial) | 2018-06-14 | — | $1,001 - $15,000 |
| Lois Frankel | 2018-06-22 | FL21 | Sale (Partial) | 2018-06-07 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| SEGALL BRYANT & HAMILL, LLC | 2026-03-31 | 4,170,189 | 73,992 | 56.36 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 32,243,556 | 572,100 | 56.36 |
| CITADEL ADVISORS LLC | 2026-03-31 | 332,524 | 5,900 | 56.36 |
| CITADEL ADVISORS LLC | 2026-03-31 | 946,848 | 16,800 | 56.36 |
| CITADEL ADVISORS LLC | 2026-03-31 | 14,549,503 | 258,153 | 56.36 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| AQR Funds | 2026-03-31 | Class R6 | QLERX | 555,164 | 31,289,043.04 | 0.3876 |
| AQR Funds | 2026-03-31 | Class N | QLENX | 555,164 | 31,289,043.04 | 0.3876 |
| AQR Funds | 2026-03-31 | Class I | QLEIX | 555,164 | 31,289,043.04 | 0.3876 |
| AQR Funds | 2026-03-31 | Class R6 | QMFRX | 1,261 | 71,069.96 | 0.3327 |
| AQR Funds | 2026-03-31 | Class I | QMFIX | 1,261 | 71,069.96 | 0.3327 |